The FDA granted final approval to Alembic's generic venetoclax tablets, rated therapeutically equivalent to Venclexta, for CLL/SLL and newly diagnosed AML.

Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a continuous decline in lung function.1,2 Affecting up to 100,000 people in the U.S. and up to 5.6 ...

In its earlier tentative-approval announcement on March 17, 2025, Lupin identified the indication as Lambert-Eaton myasthenic syndrome (LEMS) in adults and children aged six and older. LEMS is a rare ...

Please provide your email address to receive an email when new articles are posted on . Nerandomilast is the first oral preferential phosphodiesterase 4B inhibitor approved for progressive pulmonary ...

New symptoms in older adults may signal medication-related adverse effects, prompting clinicians to review existing ...

Doxycycline is a generic drug that comes in several forms, including oral tablets, capsules, and delayed-release oral tablets. It’s approved for several conditions in adults and some children. In ...

Bactrim (sulfamethoxazole/trimethoprim) is a prescription oral tablet used to treat and prevent certain types of bacterial infections. Your dosage will depend on the ...

AbbVie ( ABBV) announced that the U.S. FDA has approved JUVMO (tavapadon) tablets for the treatment of adults with Parkinson's disease, providing a new oral treatment option for a progressive ...

Insmed Incorporated announced the commercial launch in Japan of BRINSUPRI Tablets 25 mg (brensocatib hydrate), an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and ...

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. “Progressive pulmonary fibrosis is linked to ...